Warning: The NCBI web site requires JavaScript to function. more...
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.
Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G.
Arthritis Res Ther. 2009;11(1):R22. Epub 2009 Feb 16.
Related citations
Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort.
Hanke K, Dähnrich C, Brückner CS, Huscher D, Becker M, Jansen A, Meyer W, Egerer K, Hiepe F, Burmester GR, Schlumberger W, Riemekasten G.
Arthritis Res Ther. 2009;11(1):R28. Epub 2009 Feb 21.
Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
Rozman B, Cucnik S, Sodin-Semrl S, Czirják L, Varjú C, Distler O, Huscher D, Aringer M, Steiner G, Matucci-Cerinic M, Guiducci S, Stamenkovic B, Stankovic A, Kveder T.
Ann Rheum Dis. 2008 Sep;67(9):1282-6. Epub 2007 Dec 6.
Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
Maes L, Blockmans D, Verschueren P, Westhovens R, De Beéck KO, Vermeersch P, Van den Bergh K, Burlingame RW, Mahler M, Bossuyt X.
Clin Chim Acta. 2010 Jul 4;411(13-14):965-71. Epub 2010 Mar 25.
Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y.
J Dermatol. 2010 Jan;37(1):42-53. Review.
Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
Mahler M, Raijmakers R.
Autoimmun Rev. 2007 Aug;6(7):432-7. Epub 2007 Feb 20. Review.
Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
Schnitz W, Taylor-Albert E, Targoff IN, Reichlin M, Scofield RH.
J Rheumatol. 1996 Oct;23(10):1729-33.
Autoantibodies as predictive tools in systemic sclerosis.
Nihtyanova SI, Denton CP.
Nat Rev Rheumatol. 2010 Feb;6(2):112-6.
Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies.
Spencer-Green G, Alter D, Welch HG.
Am J Med. 1997 Sep;103(3):242-8. Review.
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
Franceschini F, Cavazzana I, Generali D, Quinzanini M, Viardi L, Ghirardello A, Doria A, Cattaneo R.
J Rheumatol. 2002 Jul;29(7):1393-7.
Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.
Mahler M, Greidinger EL, Szmyrka M, Kromminga A, Fritzler MJ.
Ann N Y Acad Sci. 2007 Aug;1109:311-21.
Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.
Mahler M, Raijmakers R, Dähnrich C, Blüthner M, Fritzler MJ.
Arthritis Res Ther. 2005;7(3):R704-13. Epub 2005 Apr 1.
Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA Jr.
Arthritis Rheum. 1992 Oct;35(10):1211-7.
Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
Harvey GR, Butts S, Rands AL, Patel Y, McHugh NJ.
Clin Exp Immunol. 1999 Aug;117(2):395-402.
Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients.
Vandergheynst F, Ocmant A, Sordet C, Humbel RL, Goetz J, Roufosse F, Cogan E, Sibilia J.
Clin Exp Rheumatol. 2006 Mar-Apr;24(2):129-33.
The clinical relevance of autoantibodies in scleroderma.
Ho KT, Reveille JD.
Arthritis Res Ther. 2003;5(2):80-93. Epub 2003 Feb 12. Review.
C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
Schilders G, Egberts WV, Raijmakers R, Pruijn GJ.
Arthritis Rheum. 2007 Jul;56(7):2449-54.
Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, Steen VD, Medsger TA Jr.
J Rheumatol. 2006 May;33(5):1004-13. Epub 2006 Apr 1.
Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K, Hoch S, Dima C, Varga J, Teodorescu M.
J Rheumatol. 2000 Jan;27(1):142-8.
[Antinucleolar antibodies in diagnostics of antiphospholipid syndrome].
Zabek J, Palacz A, Pyka J, Krzewska I.
Pol Arch Med Wewn. 2008;118 Suppl:25-30. Polish.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on